Literature DB >> 29780704

A promising result of locoregional tumor control with biologically adaptive radiotherapy in patients with locally advanced non-small cell lung cancer.

Yukinori Matsuo1.   

Abstract

Entities:  

Year:  2018        PMID： 29780704      PMCID： PMC5943219          DOI： 10.21037/tlcr.2018.03.01

Source DB:  PubMed          Journal:  Transl Lung Cancer Res        ISSN： 2218-6751


× No keyword cloud information.
  7 in total

1.  Local Control and Toxicity of Adaptive Radiotherapy Using Weekly CT Imaging: Results from the LARTIA Trial in Stage III NSCLC.

Authors:  Sara Ramella; Michele Fiore; Sonia Silipigni; Maria Cristina Zappa; Massimo Jaus; Antonio Maria Alberti; Paolo Matteucci; Elisabetta Molfese; Patrizia Cornacchione; Carlo Greco; Lucio Trodella; Edy Ippolito; Rolando Maria D'Angelillo
Journal:  J Thorac Oncol       Date:  2017-04-17       Impact factor: 15.609

Review 2.  Monitoring treatment response in patients undergoing chemoradiotherapy for locally advanced uterine cervical cancer by additional diffusion-weighted imaging: A systematic review.

Authors:  Sanne M Schreuder; Rutger Lensing; Jaap Stoker; Shandra Bipat
Journal:  J Magn Reson Imaging       Date:  2014-10-24       Impact factor: 4.813

3.  Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  P E Postmus; K M Kerr; M Oudkerk; S Senan; D A Waller; J Vansteenkiste; C Escriu; S Peters
Journal:  Ann Oncol       Date:  2017-07-01       Impact factor: 32.976

Review 4.  Role of interim 18F-FDG-PET/CT for the early prediction of clinical outcomes of Non-Small Cell Lung Cancer (NSCLC) during radiotherapy or chemo-radiotherapy. A systematic review.

Authors:  Marta Cremonesi; Laura Gilardi; Mahila Esmeralda Ferrari; Gaia Piperno; Laura Lavinia Travaini; Robert Timmerman; Francesca Botta; Guido Baroni; Chiara Maria Grana; Sara Ronchi; Delia Ciardo; Barbara Alicja Jereczek-Fossa; Cristina Garibaldi; Roberto Orecchia
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-07-05       Impact factor: 9.236

5.  Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.

Authors:  Jeffrey D Bradley; Rebecca Paulus; Ritsuko Komaki; Gregory Masters; George Blumenschein; Steven Schild; Jeffrey Bogart; Chen Hu; Kenneth Forster; Anthony Magliocco; Vivek Kavadi; Yolanda I Garces; Samir Narayan; Puneeth Iyengar; Cliff Robinson; Raymond B Wynn; Christopher Koprowski; Joanne Meng; Jonathan Beitler; Rakesh Gaur; Walter Curran; Hak Choy
Journal:  Lancet Oncol       Date:  2015-01-16       Impact factor: 41.316

6.  Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer.

Authors:  Scott J Antonia; Augusto Villegas; Davey Daniel; David Vicente; Shuji Murakami; Rina Hui; Takashi Yokoi; Alberto Chiappori; Ki H Lee; Maike de Wit; Byoung C Cho; Maryam Bourhaba; Xavier Quantin; Takaaki Tokito; Tarek Mekhail; David Planchard; Young-Chul Kim; Christos S Karapetis; Sandrine Hiret; Gyula Ostoros; Kaoru Kubota; Jhanelle E Gray; Luis Paz-Ares; Javier de Castro Carpeño; Catherine Wadsworth; Giovanni Melillo; Haiyi Jiang; Yifan Huang; Phillip A Dennis; Mustafa Özgüroğlu
Journal:  N Engl J Med       Date:  2017-09-08       Impact factor: 91.245

7.  Effect of Midtreatment PET/CT-Adapted Radiation Therapy With Concurrent Chemotherapy in Patients With Locally Advanced Non-Small-Cell Lung Cancer: A Phase 2 Clinical Trial.

Authors:  Feng-Ming Kong; Randall K Ten Haken; Matthew Schipper; Kirk A Frey; James Hayman; Milton Gross; Nithya Ramnath; Khaled A Hassan; Martha Matuszak; Timothy Ritter; Nan Bi; Weili Wang; Mark Orringer; Kemp B Cease; Theodore S Lawrence; Gregory P Kalemkerian
Journal:  JAMA Oncol       Date:  2017-10-01       Impact factor: 31.777
  7 in total
  2 in total

Review 1.  GOECP/SEOR radiotheraphy guidelines for non-small-cell lung cancer.

Authors:  Núria Rodríguez De Dios; Arturo Navarro-Martin; Cristina Cigarral; Rodolfo Chicas-Sett; Rafael García; Virginia Garcia; Jose Antonio Gonzalez; Susana Gonzalo; Mauricio Murcia-Mejía; Rogelio Robaina; Amalia Sotoca; Carmen Vallejo; German Valtueña; Felipe Couñago
Journal:  World J Clin Oncol       Date:  2022-04-24

2.  Adaptive carbon ion radiotherapy for locally advanced non-small cell lung cancer: Organ-sparing potential and target coverage.

Authors:  Shubing Jia; Jian Chen; Ningyi Ma; Jingfang Zhao; Jingfang Mao; Guoliang Jiang; Jiade Lu; Kailiang Wu
Journal:  Med Phys       Date:  2022-03-25       Impact factor: 4.506
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.